Despite emerging as the top seller of legal cannabis in the U.S., according to cannabis analytics firm BDSA, surpassing California in unit sales, marijuana sales remained relatively flat in May, according to the latest data by the Cannabis Regulatory Agency.
Michiganders spent a total of $279.6 million on cannabis last month, representing a 13.7% year-over-year and 0.4% increase from April.
Of that sum, medical cannabis sales accounted for $1.6 million, representing a 77.2% year-over-year and $13.5% sequential decrease. That said, recreational cannabis sales grew 16.4% year-over-year and 0.5% sequentially to $278 million.
See also: March Sales Top $288M In Another Record-Breaking Month For Michigan Cannabis Industry
Medical cannabis customers spent $592,671 on flower, $494,908 on vape cartridges and $161,830 on infused edibles, reported Green Market Report.
Flower remained the most sought product category among those seeking recreational cannabis, accounting for $124.3 million of adult-use sales for the month. That's a slight increase from $124.1 million in the previous month. Vape cartridges were the second most popular product category, followed by inhalable concentrate and infused edibles.
As Benzinga's Patricio Liddle recently highlighted "Michigan's lower tax rates and stronger enforcement against illegal operations have pushed consumers into the legal market." Moreover, the neighboring states do not have legal recreational cannabis, attracting out-of-state customers.
As of the end of May, Michigan had 2,227 active adult-use cannabis business licenses and 1,764 active medical licenses.
Now read: EXCLUSIVE: Decoding Michigan’s Cannabis Boom – Record Sales Of $3B And $457M In Taxes In 2023
To learn more about latest trends in cannabis, come, join us at the upcoming Benzinga cannabis event.
The Benzinga Cannabis Market Spotlight takes place in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don't miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code “JAVIER20” for 20% off!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.